Effect of SLCO1B1 Polymorphisms on High‐Dose Methotrexate Clearance in Children and Young Adults With Leukemia and Lymphoblastic Lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of SLCO1B1 Polymorphisms on High‐Dose Methotrexate Clearance in Children and Young Adults With Leukemia and Lymphoblastic Lymphoma

Published:2020-09-25 Issue:1 Volume:14 Page:343-353
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Schulte Rachael R.¹,Choi Leena²,Utreja Nipun¹,Van Driest Sara L.³,Stein C. Michael⁴,Ho Richard H.¹

Affiliation:

1. Department of Pediatrics Division of Pediatric Hematology/Oncology Vanderbilt University Medical Center Nashville Tennessee USA

2. Department of Biostatistics Vanderbilt University Medical Center Nashville Tennessee USA

3. Department of Pediatrics Division of General Pediatrics Vanderbilt University Medical Center Nashville Tennessee USA

4. Department of Medicine Division of Clinical Pharmacology Vanderbilt University Medical Center Nashville Tennessee USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12879

Reference39 articles.

1. Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232

2. Lymphoblastic lymphoma in children and adolescents: review of current challenges and future opportunities

3. Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the Children's Oncology Group

4. Preventing and Managing Toxicities of High-Dose Methotrexate

5. Variability in methotrexate serum and cerebrospinal fluid pharmacokinetics in children with acute lymphocytic leukemia: relation to assay methodology and physiological variables

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticipating Leucovorin Rescue Therapy in Patients with Osteosarcoma through Methotrexate Population Pharmacokinetic Model;Pharmaceutics;2024-09-06

2. An interactive dose optimizer based on population pharmacokinetic study to guide dosing of methotrexate in Chinese patients with osteosarcoma;Cancer Chemotherapy and Pharmacology;2024-08-24

3. Relationship between the efficacy and adverse effects of methotrexate and gene polymorphism;Egyptian Journal of Medical Human Genetics;2024-08-04

4. Systematic review: genetic polymorphisms in the pharmacokinetics of high-dose methotrexate in pediatric acute lymphoblastic leukemia patients;Cancer Chemotherapy and Pharmacology;2024-07-13

5. Comprehensive Evaluation of OATP‐ and BCRP‐Mediated Drug–Drug Interactions of Methotrexate Using Physiologically‐Based Pharmacokinetic Modeling;Clinical Pharmacology & Therapeutics;2024-06-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3